Tissue heterogeneity effects in treatment plan optimization

S. M. Morrill, Mark Langer, R. G. Lane, I. I. Rosen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: There is general agreement that tissue density correction factors improve the accuracy of dose calculations. However, there is disagreement over the proper heterogeneity correction algorithm and a lack of clinical experience in using them. Therefore, there has not been widespread implementation of density correction factors into clinical practice. Furthermore, the introduction of optimized conformal therapy leads to new and radically different treatment techniques outside the clinical experience of the physician. It is essential that the effects of tissue density corrections are understood so that these types of treatments can be safely delivered. Methods and Materials: In this paper, we investigate the effect of tissue density corrections on optimized conformal type treatment planning in the thorax region. Specifically, we study the effects on treatment plans optimized without tissue density corrections, when those corrections are applied to the resulting dose distributions. These effects are compared for two different conformal techniques. Results: This study indicates that failure to include tissue density correction factors results in an increased dose of approximately 5-15%. This is consistent with published studies using conventional treatment techniques. Additionally, the high-dose region of the dose distribution expands laterally into the uninvolved lung and other normal structures. The use of dose-volume histograms to compare these distributions demonstrates that treatment plans optimized without tissue density corrections lead to an increased dose to uninvolved normal structures. This increase in dose often violates the constraints used to determine the optimal solution. Conclusions: The neglect of tissue density correction factors can result in a 5-15% increase in the delivered dose. In addition, suboptimal dose distributions are produced. To benefit from the advantages of optimized conformal therapy in the thorax, tissue density correction factors should be used.

Original languageEnglish (US)
Pages (from-to)699-706
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume30
Issue number3
DOIs
StatePublished - Oct 15 1994
Externally publishedYes

Fingerprint

optimization
dosage
Therapeutics
thorax
Thorax
therapy
physicians
histograms
lungs
Physicians
planning
Lung

Keywords

  • Heterogeneity corrections
  • Optimization
  • Treatment planning

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Tissue heterogeneity effects in treatment plan optimization. / Morrill, S. M.; Langer, Mark; Lane, R. G.; Rosen, I. I.

In: International Journal of Radiation Oncology Biology Physics, Vol. 30, No. 3, 15.10.1994, p. 699-706.

Research output: Contribution to journalArticle

Morrill, S. M. ; Langer, Mark ; Lane, R. G. ; Rosen, I. I. / Tissue heterogeneity effects in treatment plan optimization. In: International Journal of Radiation Oncology Biology Physics. 1994 ; Vol. 30, No. 3. pp. 699-706.
@article{627c643502304d1dacedd9cac3940491,
title = "Tissue heterogeneity effects in treatment plan optimization",
abstract = "Purpose: There is general agreement that tissue density correction factors improve the accuracy of dose calculations. However, there is disagreement over the proper heterogeneity correction algorithm and a lack of clinical experience in using them. Therefore, there has not been widespread implementation of density correction factors into clinical practice. Furthermore, the introduction of optimized conformal therapy leads to new and radically different treatment techniques outside the clinical experience of the physician. It is essential that the effects of tissue density corrections are understood so that these types of treatments can be safely delivered. Methods and Materials: In this paper, we investigate the effect of tissue density corrections on optimized conformal type treatment planning in the thorax region. Specifically, we study the effects on treatment plans optimized without tissue density corrections, when those corrections are applied to the resulting dose distributions. These effects are compared for two different conformal techniques. Results: This study indicates that failure to include tissue density correction factors results in an increased dose of approximately 5-15{\%}. This is consistent with published studies using conventional treatment techniques. Additionally, the high-dose region of the dose distribution expands laterally into the uninvolved lung and other normal structures. The use of dose-volume histograms to compare these distributions demonstrates that treatment plans optimized without tissue density corrections lead to an increased dose to uninvolved normal structures. This increase in dose often violates the constraints used to determine the optimal solution. Conclusions: The neglect of tissue density correction factors can result in a 5-15{\%} increase in the delivered dose. In addition, suboptimal dose distributions are produced. To benefit from the advantages of optimized conformal therapy in the thorax, tissue density correction factors should be used.",
keywords = "Heterogeneity corrections, Optimization, Treatment planning",
author = "Morrill, {S. M.} and Mark Langer and Lane, {R. G.} and Rosen, {I. I.}",
year = "1994",
month = "10",
day = "15",
doi = "10.1016/0360-3016(92)90958-K",
language = "English (US)",
volume = "30",
pages = "699--706",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Tissue heterogeneity effects in treatment plan optimization

AU - Morrill, S. M.

AU - Langer, Mark

AU - Lane, R. G.

AU - Rosen, I. I.

PY - 1994/10/15

Y1 - 1994/10/15

N2 - Purpose: There is general agreement that tissue density correction factors improve the accuracy of dose calculations. However, there is disagreement over the proper heterogeneity correction algorithm and a lack of clinical experience in using them. Therefore, there has not been widespread implementation of density correction factors into clinical practice. Furthermore, the introduction of optimized conformal therapy leads to new and radically different treatment techniques outside the clinical experience of the physician. It is essential that the effects of tissue density corrections are understood so that these types of treatments can be safely delivered. Methods and Materials: In this paper, we investigate the effect of tissue density corrections on optimized conformal type treatment planning in the thorax region. Specifically, we study the effects on treatment plans optimized without tissue density corrections, when those corrections are applied to the resulting dose distributions. These effects are compared for two different conformal techniques. Results: This study indicates that failure to include tissue density correction factors results in an increased dose of approximately 5-15%. This is consistent with published studies using conventional treatment techniques. Additionally, the high-dose region of the dose distribution expands laterally into the uninvolved lung and other normal structures. The use of dose-volume histograms to compare these distributions demonstrates that treatment plans optimized without tissue density corrections lead to an increased dose to uninvolved normal structures. This increase in dose often violates the constraints used to determine the optimal solution. Conclusions: The neglect of tissue density correction factors can result in a 5-15% increase in the delivered dose. In addition, suboptimal dose distributions are produced. To benefit from the advantages of optimized conformal therapy in the thorax, tissue density correction factors should be used.

AB - Purpose: There is general agreement that tissue density correction factors improve the accuracy of dose calculations. However, there is disagreement over the proper heterogeneity correction algorithm and a lack of clinical experience in using them. Therefore, there has not been widespread implementation of density correction factors into clinical practice. Furthermore, the introduction of optimized conformal therapy leads to new and radically different treatment techniques outside the clinical experience of the physician. It is essential that the effects of tissue density corrections are understood so that these types of treatments can be safely delivered. Methods and Materials: In this paper, we investigate the effect of tissue density corrections on optimized conformal type treatment planning in the thorax region. Specifically, we study the effects on treatment plans optimized without tissue density corrections, when those corrections are applied to the resulting dose distributions. These effects are compared for two different conformal techniques. Results: This study indicates that failure to include tissue density correction factors results in an increased dose of approximately 5-15%. This is consistent with published studies using conventional treatment techniques. Additionally, the high-dose region of the dose distribution expands laterally into the uninvolved lung and other normal structures. The use of dose-volume histograms to compare these distributions demonstrates that treatment plans optimized without tissue density corrections lead to an increased dose to uninvolved normal structures. This increase in dose often violates the constraints used to determine the optimal solution. Conclusions: The neglect of tissue density correction factors can result in a 5-15% increase in the delivered dose. In addition, suboptimal dose distributions are produced. To benefit from the advantages of optimized conformal therapy in the thorax, tissue density correction factors should be used.

KW - Heterogeneity corrections

KW - Optimization

KW - Treatment planning

UR - http://www.scopus.com/inward/record.url?scp=0027980407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027980407&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(92)90958-K

DO - 10.1016/0360-3016(92)90958-K

M3 - Article

C2 - 7928503

AN - SCOPUS:0027980407

VL - 30

SP - 699

EP - 706

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -